Literature DB >> 18984082

Thrombolysis for acute central retinal artery occlusion: is it time?

Valérie Biousse.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18984082      PMCID： PMC3057486          DOI： 10.1016/j.ajo.2008.07.025

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN： 0002-9394            Impact factor:   5.258


× No keyword cloud information.
  15 in total

1.  The incidence of central retinal artery occlusion in the district of Split, Croatia.

Authors:  M Ivanisević; D Karelović
Journal:  Ophthalmologica       Date:  2001 May-Jun       Impact factor: 3.250

2.  Multicenter study of the European Assessment Group for Lysis in the Eye (EAGLE) for the treatment of central retinal artery occlusion: design issues and implications. EAGLE Study report no. 1 : EAGLE Study report no. 1.

Authors:  N Feltgen; A Neubauer; B Jurklies; C Schmoor; D Schmidt; J Wanke; H Maier-Lenz; M Schumacher
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-12-22       Impact factor: 3.117

3.  Intravenous or intra-arterial thrombolysis?: it's time to find the right approach for the right patient.

Authors:  Heinrich P Mattle
Journal:  Stroke       Date:  2007-05-31       Impact factor: 7.914

Review 4.  Intra-arterial thrombolysis for central retinal artery occlusion: a systematic review.

Authors:  J Noble; N Weizblit; M O Baerlocher; K T Eng
Journal:  Br J Ophthalmol       Date:  2008-05       Impact factor: 4.638

5.  Central retinal artery occlusion: visual outcome.

Authors:  Sohan Singh Hayreh; M Bridget Zimmerman
Journal:  Am J Ophthalmol       Date:  2005-09       Impact factor: 5.258

6.  Is intra-arterial thrombolysis safe after full-dose intravenous recombinant tissue plasminogen activator for acute ischemic stroke?

Authors:  Hashem M Shaltoni; Karen C Albright; Nicole R Gonzales; Raymond U Weir; Aslam M Khaja; Rebecca M Sugg; Morgan S Campbell; Edwin D Cacayorin; James C Grotta; Elizabeth A Noser
Journal:  Stroke       Date:  2006-11-22       Impact factor: 7.914

7.  Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.

Authors:  Randall T Higashida; Anthony J Furlan; Heidi Roberts; Thomas Tomsick; Buddy Connors; John Barr; William Dillon; Steven Warach; Joseph Broderick; Barbara Tilley; David Sacks
Journal:  Stroke       Date:  2003-07-17       Impact factor: 7.914

8.  Central retinal artery occlusion. Retinal survival time.

Authors:  Sohan Singh Hayreh; M Bridget Zimmerman; Alan Kimura; Ashish Sanon
Journal:  Exp Eye Res       Date:  2004-03       Impact factor: 3.467

9.  Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: The American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists.

Authors:  Harold P Adams; Gregory del Zoppo; Mark J Alberts; Deepak L Bhatt; Lawrence Brass; Anthony Furlan; Robert L Grubb; Randall T Higashida; Edward C Jauch; Chelsea Kidwell; Patrick D Lyden; Lewis B Morgenstern; Adnan I Qureshi; Robert H Rosenwasser; Phillip A Scott; Eelco F M Wijdicks
Journal:  Circulation       Date:  2007-05-22       Impact factor: 29.690

10.  Therapeutic decisions involving disparate clinical outcomes: patient preference survey for treatment of central retinal artery occlusion.

Authors:  C E Margo; W P Mack
Journal:  Ophthalmology       Date:  1996-04       Impact factor: 12.079
View more
  10 in total

1.  Eye syndromes and the neuro-ophthalmology of stroke.

Authors:  Valérie Biousse; Nancy J Newman
Journal:  Handb Clin Neurol       Date:  2009

2.  Acute retinal arterial ischemia.

Authors:  Michael Dattilo; Nancy J Newman; Valérie Biousse
Journal:  Ann Eye Sci       Date:  2018-06-06

3.  [Comparison of superselective intraarterial fibrinolysis with conservative therapy. Use in patients with acute non-arteritic central retinal artery occlusion].

Authors:  A Wolf; M Schumacher; A S Neubauer; C Schmoor; C Gall; B Jurklies; I Wanke; L Solymosi; H Brückmann; D Schmidt; N Feltgen
Journal:  Ophthalmologe       Date:  2010-09       Impact factor: 1.059

4.  Vascular neuro-ophthalmology.

Authors:  Cédric Lamirel; Nancy J Newman; Valérie Biousse
Journal:  Neurol Clin       Date:  2010-08       Impact factor: 3.806

5.  Successful treatment of central retinal artery thromboembolism with ocular massage and intravenous acetazolamide.

Authors:  Oliver Duxbury; Pervinder Bhogal; Geoffrey Cloud; Jeremy Madigan
Journal:  BMJ Case Rep       Date:  2014-12-05

6.  Central retinal artery occlusion and cerebral infarction associated with Mycoplasma pneumonia infection in children.

Authors:  Yunguang Bao; Xiaobing Li; Kaixuan Wang; Chan Zhao; Xiumei Ji; Mizu Jiang
Journal:  BMC Pediatr       Date:  2016-12-09       Impact factor: 2.125

7.  Evaluation of Ophthalmic Artery Branch Retrograde Intervention in the Treatment of Central Retinal Artery Occlusion (CRAO).

Authors:  Runsheng Wang; Lu Qian; Yi Wang; Yi Zheng; Shanshuang Du; Tao Lei; Peilin Lv; Tan Long; Wenjun Wang
Journal:  Med Sci Monit       Date:  2017-01-08

8.  Intra-Arterial Thrombolysis for Acute Central Retinal Artery Occlusion: A Systematic Review and Meta-Analysis.

Authors:  Paul S Page; Nicolas K Khattar; Andrew C White; Alexander C Cambon; Guy N Brock; Shesh N Rai; Robert F James
Journal:  Front Neurol       Date:  2018-02-21       Impact factor: 4.003

9.  Establishment of the reproducible branch retinal artery occlusion mouse model and intravital longitudinal imaging of the retinal CX3CR1-GFP+ cells after spontaneous arterial recanalization.

Authors:  Jehwi Jeon; Sang-Hoon Kim; Eunji Kong; Soo Jin Kim; Jee Myung Yang; Joo Yong Lee; Junyeop Lee; You-Me Kim; Pilhan Kim
Journal:  Front Med (Lausanne)       Date:  2022-07-15

10.  Treatment options for central retinal artery occlusion.

Authors:  Sudha Cugati; Daniel D Varma; Celia S Chen; Andrew W Lee
Journal:  Curr Treat Options Neurol       Date:  2013-02       Impact factor: 3.598
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.